BrianJosephJordanMD

PubMed

• Corrigendum to "Identification of Differential Tumor Subtypes of T1 Bladder Cancer" [Eur. Urol. 78 (2020) 533-537].
  A. Gordon Robertson, Clarice S. Groeneveld, Brian J. Jordan, Xiaoqi Lin, Kimberly A. McLaughlin
  European Urology. 2021-11-17
• 172 citations
  An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.
  Sia Viborg Lindskrog, Frederik Prip, Philippe Lamy, Ann Taber, Clarice S. Groeneveld
  Nature Communications. 2021-04-16
• 6 citations
  Surgeon Scorecards Improve Muscle Sampling on Transurethral Resection of Bladder Tumor and Recurrence Outcomes in Patients with Nonmuscle Invasive Bladder Cancer
  Arighno Das, Jason E. Cohen, Oliver S. Ko, Brian J. Jordan, Alexander P. Glaser
  The Journal of Urology. 2021-03-01

Journal Articles

• T1 Bladder Cancer: Current Considerations for Diagnosis and Management  
  Joshua J Meeks, Brian Jordan, Nature
• Importance of identification of prostate adenocarcinoma in urine cytology  
  Lin X, Jordan BB, Journal of American Society of Cytopathology, 2018
• The timing and frequency of infectious complications after radical cystectomy: an opportunity for rescue antibiotic treatment  
  Jordan BJ, Lewis KC, Matulewicz RS, Kundu S, Urology Practice, 2018
• Transversus abdominis plane blockade as part of a multimodal postoperative analgesia plan in patients undergoing radical cystectomy  
  Matulewicz RS, Patel M, Jordan BJ, Morano J, Frainey B, Bhanji Y, Nader A, Kundu S, Meeks J, Bladder Cancer, 2018
• Evaluation and management of failed bladder reconstructions  
  Jordan BJ, Palmer C, Kielb SJ, Curr Bladder Dysfunct Rep, 2015
• An FTIR investigation of flanking sequence effects on the structure and flexibility of DNA binding sites  
  Kahn TR, Fong KK, Jordan BJ, Lek JC, Levitan R, Mitchell PS, Wood C, Hatcher ME, Biochemistry, 2009
• Join now to see all